Skip to content
MarketScale
‹ Back to IndustriesHealthcare

Toxic Cleaners Are Being Misused and Overused During the COVID Pandemic

Never before has American society paid as much attention to cleaning products and hygiene as it is now. Yet, even in this heightened moment of hygiene, John Shanahan, President and CEO of Ionogen, said we’re still not doing even close to enough research about the products being used – and often overused – during…

This story was produced through MarketScale. See how Healthcare teams put it to work with Executive Thought Leadership.

Share

Never before has American society paid as much attention to cleaning products and hygiene as it is now.

Yet, even in this heightened moment of hygiene, John Shanahan, President and CEO of Ionogen, said we’re still not doing even close to enough research about the products being used – and often overused – during the COVID-19 pandemic. While the N list distributed by the EPA is a list of all products it expects to kill the novel coronavirus SARS-CoV-2, there are knock-on effects not being considered, according to Shanahan.

“The N list is this new ‘Gucci’ line. If you’re an N-listed product, you’re effective against the COVID virus. It’s very interesting. The EPA and FDA are agencies set aside to help us. They’re supposed to protect us, they’re supposed to keep us safe. What the EPA neglects to tell us is many products listed on the N list are toxic to human health,” Shanahan said. “We know we have to deal with this issue of COVID … We look to these venerable agencies and say please give us the guidance to protect us and keep us safe, and there are products like quaternary disinfectants.”

Too often, facility managers simply assume something is good because it’s approved for use by government agencies, yet this can set up an employer for serious financial damages in the future if employees are harmed.

“The way to understand the finances and the financial damage is we have to have a realistic example of some prior precedent,” Shanahan said. “The prior precedent was set up in the three separate lawsuits that involved Roundup as an herbicide approved by the EPA.”

In those cases, the place of employment is party to the lawsuit in addition to the manufacturer. That’s why checking safety data sheets and choosing non-toxic cleaning products can be essential.

For the latest news, videos, and podcasts in the Building Management Industry, be sure to subscribe to our industry publication.

Follow us on social media for the latest updates in B2B!

Twitter – @MarketScale

Facebook – facebook.com/marketscale

LinkedIn – linkedin.com/company/marketscale

Healthcare: are you visible to AI?

Before they reach out, Healthcare buyers ask AI engines which vendors to trust. See how AI describes your company today, and where competitors show up instead.

Free workspace

You just read one expert. Imagine publishing your whole team.

This article was produced through MarketScale. Create a free workspace and turn your own team's expertise into articles, video, and social posts. No credit card, no demo required.

NPS +73 · 1,000+ creators · 38+ countries

What you get, free

Your own MarketScale Studio workspace
One video edit a month, on us
AI writing, editing, and publishing tools
In-platform coaching to learn the system

More Healthcare Insights

FDA clears UpDoc's LLM diabetes app, grants Aidoc breakthrough status as clinical AI crosses new regulatory thresholds

FDA clears UpDoc's LLM diabetes app, grants Aidoc breakthrough status as clinical AI crosses new regulatory thresholds

UpDoc has received FDA clearance for its LLM-driven diabetes management app, while Aidoc has been granted breakthrough device status for its AI-drafted radiology reports. This marks a significant milestone as clinical AI applications continue to gain regulatory approval and recognition. The advancements showcase the potential of AI in improving healthcare management and diagnostic processes.

  • 01UpDoc's diabetes management app receives FDA clearance.
  • 02Aidoc achieves breakthrough device status for AI radiology reports.
  • 03Regulatory milestones highlight AI's growing role in healthcare.

Jul 13, 2026

Cedars-Sinai's CDAIO on healthcare AI's second wave: workforce transformation, not just productivity

Cedars-Sinai's CDAIO on healthcare AI's second wave: workforce transformation, not just productivity

The chief data and AI officer at Cedars-Sinai discusses the evolving role of AI in healthcare. While the first wave of AI focused on enhancing productivity, the second wave is expected to transform job roles and the workforce structure. This shift indicates a deeper integration of AI technology in healthcare operations.

  • 01First wave of AI increased productivity in healthcare.
  • 02Second wave aims to restructure job roles.
  • 03AI will deeply integrate into healthcare operations.

Jul 13, 2026

Automation adoption gap widens in US manufacturing as medtech presses ahead

Automation adoption gap widens in US manufacturing as medtech presses ahead

Automation in US manufacturing lags, with 80% of factories lacking automation tools. In contrast, medtech manufacturers are advancing with technologies like micro-molding and ultrasonic welding. This disparity highlights a growing gap in technology adoption across different sectors.

  • 0180% of US factories have no automation.
  • 02Medtech manufacturers are investing in automation technologies.
  • 03There's an increasing divide in technology adoption across industries.

Jul 12, 2026

Explore More Healthcare Insights

Read more expert perspectives from across Healthcare.

Browse Healthcare Hub

For B2B teams

Your experts could be publishing here

Stories like this one run on content MarketScale captures from real practitioners. See how your team's expertise becomes coverage in Healthcare and beyond.

Book a 15-minute demo

Or call us. No forms required. We pick up. 214-945-2512